Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Knowing what to include in an investment plan is vital for success. Explore essential tips to create a comprehensive investment strategy.
23,457 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Elon Musk's X Money beta rollout ignites XRP price prediction chatter as traders weigh the chances of crypto integrat...
Oracle’s $523 billion backlog raises timing concerns as capex surges. cnbc’s deirdre bosa warns that the chip upgrade...
Oil markets wrestle with tight supply, uneven demand, and policy shifts as OPEC+ keeps cuts and U.S. shale expands. H...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Bitcoin and XRP lead the 2026 debate on how to deploy $1,000 in crypto, with macro momentum and policy shifts potenti...
North Korea’s Foreign Ministry rejected cyber theft accusations as 'absurd slander,' arguing the claims are political...
Delta Air Lines and AMEX have renewed their landmark co-brand partnership, reinforcing a revenue engine that has resh...
ZoomInfo's go-to-market approach is evolving as 2026 unfolds. This analysis breaks down the GTM moves behind the earn...
A widening disconnect between executive teams and frontline operations is dragging down loan-technology upgrades. The...
AI-driven capital spending is accelerating demand for etching and related fabrication equipment, spotlighting semicon...